top of page

ABOUT US

About Us

pHion Therapeutics is a UK based biotech delivering ground-breaking nucleic acid vaccines and therapeutics.

The proprietary  RALA peptide-based drug delivery system is based on a sequence of 30 amino acids which condenses anionic cargo (RNA and DNA), irrespective of size, into nanoparticles. These nanoparticles are highly efficient at cellular entry with 100% release from the endosomes. 

 

When used in vaccines, the RALA platform can deliver multiple anionic molecules, such as mRNA, in a stealth-like way by evading detection. This generates both a potent antigen-specific CD8+ T-cell response that is ideal for therapeutic vaccines, and a long-term T-Cell and antibody memory that is ideal for prophylactic vaccines.

The platform has the added advantage of ease of scalability, using globally available mixing devices, options for lyophilised or liquid formulations, no use of solvents which results in a more sustainable product, and reduced wastage with >99% encapsulation of cargo. 

pHion’s lead product is a therapeutic vaccine against HPV driven cancers (PTX_V1), with Phase I/IIA clinical trials planned to commence in 2024.


pHion’s pipeline programs also include therapeutics against, ovarian (PTX_V5), prostate cancer (PTX _V3), and a prophylactic vaccine against Crimean-Congo Haemorrhagic Fever.

 

The company is headquartered in Belfast, Northern Ireland. invoX Pharma, an integrated global biopharmaceutical company with a diversified pipeline, is a majority shareholder of pHion Therapeutics. To learn more about invoX, visit: www.invoxpharma.com. For more information follow us on LinkedIn.

MEET THE TEAM

The pHion Therapeutics team includes inventors, scientists, and business development professionals from a variety of life sciences backgrounds.

Collectively we’re a world class drug development team.

AT1A8123.JPG

JARLATH
SMITH

HEAD OF FINANCE

  • Grey LinkedIn Icon
Laura.jpg

LAURA
KETTYLE

DIRECTOR OF PRECLINICAL VACCINES

Hayley.jpg

HAYLEY
DOUGLAS

QUality ASSURANCE AND TRAINING MANAGER

  • Grey LinkedIn Icon
Garrett.jpg

GARRETT

O'BRIEN

LABoratory manager/
SENIOR R&D 
Scientist

Lindsey.jpg

LINDSEY
BENNIE

PRINCIPAL
R&D 
Scientist

  • Grey LinkedIn Icon
Charles.jpg

CHARLES
HAUGHEY

PRINCIPAL 
R&D 
Scientist

Phion-Logo-Color_edited.png

AMY
DUMIGAN

PRINCIPAL
R&D 
Scientist

Megan.jpg

megan
KErr

Formulation 
Scientist

  • Grey LinkedIn Icon

megan
kerr

executive assistant
& finance administrator

  • Grey LinkedIn Icon
Emma.jpg

emma 
carroll

 

R&D Scientist

Sarah.jpg

SARAH
KUHN

R&D SCIENTIST

  • Grey LinkedIn Icon
Phion-Logo-Color_edited.png

aishwarya
khadanga

 

r&d scientist

AT1A8105.JPG

maria
grogan

executive assistant
& finance administrator

Phion-Logo-Color_edited.png

ronan
auld

formulation 
scientist

Phion-Logo-Color_edited.png

emma
adams

formulation
scientist

Phion-Logo-Color_edited.png

conor
breen

senior R&D
TECHNICIAN

Denise.jpg

DENISE
MCGRADY

LABORATORY
TECHNICIAN

Meet The Team
Darach_edited.jpg

DARACH
NEESON

COO

  • Grey LinkedIn Icon
Monika.jpg

Monika
Ziminska

director of
PROGRAMME
delivery

  • Grey LinkedIn Icon
Cian.jpg

cian
mccrudden

HEAD OF vaccine
DEVELOPMENT

  • Grey LinkedIn Icon
AT1A8078.JPG

CLARE
GREENWOOD

HEAD OF STRATEGIC PROJECT DELIVERY

  • Grey LinkedIn Icon
Board of Directors

BOARD OF DIRECTORS

BOARD OF DIRECTORS

Ben.jpg

BEN
TOOGOOD

chairperson

  • Grey LinkedIn Icon
John.jpg

john
fox

DIRECTOR

  • Grey LinkedIn Icon
George.jpg

george
orphanides

DIRECTOR

  • Grey LinkedIn Icon

Find Out More

bottom of page